Skip to main content
. 2015 Jun 30;113(1):37–45. doi: 10.1038/bjc.2015.209

Figure 3.

Figure 3

Forest plots for (A) PFS and (B) OS for groups with different levels of VEGF-D expression. *Hazard ratio for all patients in the MAX trial, including those whose tumour samples were not analysed.